Madrid, Spain | FLAVIA NASSAKA | A global HIV conference opened on Oct.22 in Madrid, Spain bringing together researchers to discuss strides made in prevention of infections.
Dubbed HIV Research for Prevention (HIVR4P) 2018, the week long event which happens every two years will focus on several new prevention innovations. The new innovations are Pre-Exposure Prophylaxis (PrEP) which involves giving HIV drugs to negative people at risk of infection as prevention, progress on the search for the vaccine, treatment as prevention and microbicides such as the ARV laced vaginal ring, implants among others.
Commenting on PrEP, San Francisco based researcher Susan Buchbinder said presenters will give updates on retention on PrEP, its impact so far and the inject able PrEP – carbortagravir which has not yet been rolled out in some places especially in Africa.
Speaking at the opening press conference on Monday, Jose Alcami one of the event’s organizers said the conference will provide an opportunity for researchers to share notes on especially what’s happening in as far as finding a vaccine is concerned.